109906
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.4 Breast Cancer (Dove Med Press)
- 3.2 Clin Epidemiol
- 2.6 Cancer Manag Res
- 2.9 Infect Drug Resist
- 3.7 Clin Interv Aging
- 5.1 Drug Des Dev Ther
- 3.1 Int J Chronic Obstr
- 6.6 Int J Nanomed
- 2.6 Int J Women's Health
- 2.9 Neuropsych Dis Treat
- 2.8 OncoTargets Ther
- 2.0 Patient Prefer Adher
- 2.2 Ther Clin Risk Manag
- 2.5 J Pain Res
- 3.0 Diabet Metab Synd Ob
- 3.2 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 1.8 Pharmgenomics Pers Med
- 2.0 Risk Manag Healthc Policy
- 4.1 J Inflamm Res
- 2.0 Int J Gen Med
- 3.4 J Hepatocell Carcinoma
- 3.0 J Asthma Allergy
- 2.2 Clin Cosmet Investig Dermatol
- 2.4 J Multidiscip Healthc
已发表论文
网络药理学结合动物实验阐明新安方治疗变应性鼻炎的作用机制
Received 1 July 2025
Accepted for publication 29 October 2025
Published 3 November 2025 Volume 2025:18 Pages 15357—15378
DOI https://doi.org/10.2147/JIR.S550848
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Dr Tara Strutt
Ming Zhang,1 Ruohui Song2
1Department of Otorhinolaryngology, The First School of Clinical of Anhui University of Chinese Medicine, Hefei, Anhui, 230012, People’s Republic of China; 2Department of Otorhinolaryngology, The First Affiliated Hospital of Anhui University of CM, Hefei, Anhui, 230031, People’s Republic of China
Correspondence: Ruohui Song, Department of Otorhinolaryngology, The First Affiliated Hospital of Anhui University of CM, 117 Meishan Road, Shushan District, Hefei, Anhui, 62850080, People’s Republic of China, Email qming659@126.com
Purpose: Exploring the mechanism of the effect of Xin’an BiYan Formula (XBY) in treating allergic rhinitis (AR) using network pharmacology combined with animal experiments.
Methods: Key targets for AR treatment were identified through multi-database and PPI network screening. Potential signaling pathways were predicted by conducting Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses. The predicted targets and pathways in animal experiments to learn XBY’s effects on inflammation and apoptosis in nasal mucosal tissue cells during AR development.
Results: Screening identified 18 principal targets of XBY in AR: TNF, AKT1, HIF1A, MMP9, BCL2, EGFR, IL-2, PTGS2, VCAM-1, PTGS1, ACE, PPARG, ICAM-1, SIRT1, ITGB1, JAK2, RELA, and KIT. The key pharmacological constituents included Genkwanin, Calycosin, Kaempferol, and Luteolin. GO and KEGG enrichment analyses revealed significant enrichment in the PI3K/AKT, Apoptosis, and NF-kappa B signaling pathways. After XBY treatment, infiltration of eosinophils (EOS) and mast cells (MC) in the nasal mucosa of AR model mice was reduced. Concurrently, serum levels of IL-6, TNF-α, COX-2, Total-IgE, OVA-IgE, ICAM-1, and VCAM-1 were decreased. Mucosal levels of p-PI3K/PI3K, p-AKT/AKT, p-n-p65/c-p65, p-IKKβ/ IKKβ, and Bcl-2 proteins were decreased, while Bax, Cleaved-Caspase3, and Caspase-3 protein expression were increased. Cellular levels of reactive oxygen species(ROS) and apoptosis levels were reduced.
Conclusion: The experimental results indicate that the therapeutic effect of XBY on AR is likely mediated through modulation of the ROS/PI3K/AKT/NFκB signaling pathway. By reducing inflammatory cell infiltration, downregulating the expression of inflammatory and adhesion factors, and modulating apoptosis proteins to accelerate inflammatory cell apoptosis, dual mechanisms effectively inhibit the progression of inflammation. This study holds potential translational prospects and may provide new insights for the treatment of AR with TCM.
Keywords: network pharmacology, allergic rhinitis, traditional Chinese medicine, PI3K/AKT signaling pathway, inflammation
1Department of Otorhinolaryngology, The First School of Clinical of Anhui University of Chinese Medicine, Hefei, Anhui, 230012, People’s Republic of China; 2Department of Otorhinolaryngology, The First Affiliated Hospital of Anhui University of CM, Hefei, Anhui, 230031, People’s Republic of China
Correspondence: Ruohui Song, Department of Otorhinolaryngology, The First Affiliated Hospital of Anhui University of CM, 117 Meishan Road, Shushan District, Hefei, Anhui, 62850080, People’s Republic of China, Email qming659@126.com
Purpose: Exploring the mechanism of the effect of Xin’an BiYan Formula (XBY) in treating allergic rhinitis (AR) using network pharmacology combined with animal experiments.
Methods: Key targets for AR treatment were identified through multi-database and PPI network screening. Potential signaling pathways were predicted by conducting Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses. The predicted targets and pathways in animal experiments to learn XBY’s effects on inflammation and apoptosis in nasal mucosal tissue cells during AR development.
Results: Screening identified 18 principal targets of XBY in AR: TNF, AKT1, HIF1A, MMP9, BCL2, EGFR, IL-2, PTGS2, VCAM-1, PTGS1, ACE, PPARG, ICAM-1, SIRT1, ITGB1, JAK2, RELA, and KIT. The key pharmacological constituents included Genkwanin, Calycosin, Kaempferol, and Luteolin. GO and KEGG enrichment analyses revealed significant enrichment in the PI3K/AKT, Apoptosis, and NF-kappa B signaling pathways. After XBY treatment, infiltration of eosinophils (EOS) and mast cells (MC) in the nasal mucosa of AR model mice was reduced. Concurrently, serum levels of IL-6, TNF-α, COX-2, Total-IgE, OVA-IgE, ICAM-1, and VCAM-1 were decreased. Mucosal levels of p-PI3K/PI3K, p-AKT/AKT, p-n-p65/c-p65, p-IKKβ/ IKKβ, and Bcl-2 proteins were decreased, while Bax, Cleaved-Caspase3, and Caspase-3 protein expression were increased. Cellular levels of reactive oxygen species(ROS) and apoptosis levels were reduced.
Conclusion: The experimental results indicate that the therapeutic effect of XBY on AR is likely mediated through modulation of the ROS/PI3K/AKT/NFκB signaling pathway. By reducing inflammatory cell infiltration, downregulating the expression of inflammatory and adhesion factors, and modulating apoptosis proteins to accelerate inflammatory cell apoptosis, dual mechanisms effectively inhibit the progression of inflammation. This study holds potential translational prospects and may provide new insights for the treatment of AR with TCM.
Keywords: network pharmacology, allergic rhinitis, traditional Chinese medicine, PI3K/AKT signaling pathway, inflammation